Levofloxacin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin.
Teo
Wan Lin
WL
Pang
Shiu Ming
SM
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D064704:Levofloxacin; D015242:Ofloxacin / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy* / Q000209:etiology
D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D064704:Levofloxacin; D015242:Ofloxacin